Treatment of Organophosphorus Exposure and Precautions in Using Succinylcholine
,
Abstract
No Abstract No Abstract No Abstract
[1] Eddleston M, Dawson A, Karalliedde L, Dissanayake W, Hittarage A, Azher S, et al. Early management after self-poisoning with an organophosphorus or carbamate pesticide - a treatment protocol for junior doctors. Crit Care. 2004; 8(6):R391-7.
[2] Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM. 2002; 95(5):275-83.
[3] Ballantyne B, Marrs TC. Overview of the biological and clinical aspects of organophosphates and carbamates. In Clinical and Experimental Toxicology of Organophosphates and Carbamates. (Edited by: Ballantyne B, Marrs TC). Oxford: Butterworth Heinemann 1992, 3-14.
[4] Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol. 2002; 76(9):523-9.
[5] Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev. 2003, 22(3):165-190.
[6] Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet. 2008; 371: 597–607.
[7] Worek F, Diepold C, Eyer P. Dimethylphodphoryl-inhibited human cholinesterase: inhibition, reactivation and aging kinetics. Arch Toxicol. 1999; 73:7-14.
[8] Cherian MA, Roshini C, Peter JV, Cherian MA. Oximes in organophosphorus poisoning. Indian J Crit Care Med. 2005; 9(3):155-163.
[9] De Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning. Lancet. 1992; 339:1136–8.
[10] Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology. 2006; 104(1):158-69.
[11] Sungur M, Güven M: Intensive care management of organophosphate insecticide poisoning. Crit Care. 2001; 5: 211-215.
[12] Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med. 2000; 12: 22-37.
[2] Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM. 2002; 95(5):275-83.
[3] Ballantyne B, Marrs TC. Overview of the biological and clinical aspects of organophosphates and carbamates. In Clinical and Experimental Toxicology of Organophosphates and Carbamates. (Edited by: Ballantyne B, Marrs TC). Oxford: Butterworth Heinemann 1992, 3-14.
[4] Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol. 2002; 76(9):523-9.
[5] Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev. 2003, 22(3):165-190.
[6] Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet. 2008; 371: 597–607.
[7] Worek F, Diepold C, Eyer P. Dimethylphodphoryl-inhibited human cholinesterase: inhibition, reactivation and aging kinetics. Arch Toxicol. 1999; 73:7-14.
[8] Cherian MA, Roshini C, Peter JV, Cherian MA. Oximes in organophosphorus poisoning. Indian J Crit Care Med. 2005; 9(3):155-163.
[9] De Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning. Lancet. 1992; 339:1136–8.
[10] Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology. 2006; 104(1):158-69.
[11] Sungur M, Güven M: Intensive care management of organophosphate insecticide poisoning. Crit Care. 2001; 5: 211-215.
[12] Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med. 2000; 12: 22-37.
| Files | ||
| Issue | Vol 9 No 1 (2023): Winter |
|
| Section | Editorial | |
| DOI | https://doi.org/10.18502/aacc.v9i1.11935 | |
| Keywords | ||
| Organophosphorus toxicity Succinylcholine pralidoxime | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Jabbari A, Najafi A, Khori V, Hussain Khan Z. Treatment of Organophosphorus Exposure and Precautions in Using Succinylcholine. Arch Anesth & Crit Care. 2023;9(1):1-3.
